• Skills People And Talent

New HealthTech directorship at CPI to boost innovation that will urgently improve global health and care

We’re pleased to announce that we’ve appointed Rahul Kapoor as our first HealthTech Director, marking our purposeful shift toward HealthTech.

Agility Life Sciences CEO makes Medicine Maker Power List debut

Prof. Claire Thompson, multi award-winning CEO of Agility Life Sciences, has been recognised as one of the Top 10 Leaders in the field of small molecules on the 2022 Medicine Maker Power List.

Relation Therapeutics names David Roblin as CEO and Lindsay Edwards as CTO

DCVC and Magnetic Ventures co-led a $25 million seed financing, with participation from Khosla Ventures, OMERS Ventures, and firstminute Capital, among others

Metrion Biosciences appoints Dr Benedetta Montagnini as Head of European Business Development

Expansion of European business development team supports next phase of growth for Metrion’s ion channel drug discovery services

Coulter Partners: Top global hires Large-cap, mid-cap and public companies

We recap our top global hires for large-cap, mid-cap and public companies since last November, which covered a broad range of disciplines and sectors across life sciences.

CEO Update | 30 May 2022

As we celebrate the Queen’s Platinum Jubilee it was great to see the King and Queen of Sweden visiting AstraZeneca in Cambridge last week. The visit provided the platform for the UK government to sign its first Memorandum of Understanding (MoU) with Sweden regarding life sciences. The MoU promises to lead to "enhancing cooperation between our governments and to galvanise our life sciences ecosystems in working together on our shared strengths and common priorities, covering fields from precision medicine, clinical trials, pandemic preparedness and antimicrobial resistance to sustainability, trade, and investment for the sector."

CN Bio appoints Dr Paul Brooks as Chief Business Officer

CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks as Chief Business Officer.

New study highlights talent needed to grow the biosimilars sector

The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity® Reports: Biosimilars 2022. The new report features interviews with leaders of biosimilars companies who give their unique insights into the challenges and opportunities facing this fast-growing sector and the leadership needed to grow the industry, including the power of creating strong in-house knowledge and evaluating where this talent already exists.

Coulter Partners places Group COO at Helsinn supporting expansion in senior leadership team

Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health, and Tech, recently partnered with Helsinn Group, a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, and was pleased to secure the appointment of Dr Melanie Rolli as Group Chief Operating Officer (COO).

Coulter Partners places Chief Operating Officer at Treadwell Therapeutics, playing an integral role in the company’s evolution

Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health, and Tech, recently partnered with Treadwell Therapeutics, a clinical-stage biotechnology company developing novel, cross-modality medicines for unmet needs in cancer, and are pleased to announce the placement of J.D. Mowery as Chief Operating Officer (COO).